NCT05947149Recruiting
HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
Health Related Quality of Life (HRQoL) in Patients With Solid Tumors Treated With Hadrontherapy (HadroQoL).
Source: ClinicalTrials.gov · Last updated 6 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Quality of Life of patients treated with hadrontherapy is still limited. Two cohorts are established, they will be receiving specific standardized questionnaires to be evalutaed in their results.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 180 (estimated)
- First submitted
- 7 Jul 2023
- Start date
- 27 Mar 2023
- Primary completion date
- 26 Sept 2025
- Lead sponsor
- CNAO National Center of Oncological Hadrontherapy
- Diseases
- Head and neck cancer
- NCT number
- NCT05947149
What you commit to
- Study type: Observational
- Planned participants: 180
- From 27 Mar 2023 to the primary completion date, 26 Sept 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Re-irradiation.
- Re-irradiation.
Other illness
- Known cases of any psychiatric and neurological diseases leading to disability (eg, manic disorder, schizophrenia etc..), which could impair compilation of questionnaires or affect quality of life.
- Cohort B:
- Known cases of any psychiatric and neurological diseases leading to disability (eg, manic disorder, schizophrenia etc..), which could impair compilation of questionnaires or affect quality of life
Other
- Second tumor.
- Second tumor
- Presence of diffused metastasis
Who the study is looking for
- Patients with at least a follow up of 5 years with head and neck, skull base and brain tumors and no evidence of progressive disease.
- The patient is able to give consent
- Histological and/or radiological diagnosis of head and neck tumors
- Patients candidate for curative intent hadrontherapy
- Patients ≥ 18 years of age
- The patient is able to give consent
Criteria the registry did not label
- Cohort A ("survivors"):
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CNAO Coordinator of this site? Confirm its status | Pavia | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.